Partnering & Outsourcing Editorial

1. Running Global Clinical Trials? PolyPid Shares Operational And Regulatory Insights 8/11/2025

   PolyPid shares its clinical trial journey across the U.S., Europe, and Israel, highlighting operational complexities, regulatory navigation, and the adaptability required to execute large-scale, global studies. 

2. Why CRO Site Network Strategies Confuse Me 8/6/2025

   As CROs evolve beyond traditional service roles, many are investing in proprietary or semi-integrated site networks to streamline trial delivery, improve patient access, and boost data consistency. This article explores how major players like ICON, Parexel, PPD, and Syneos Health are building or partnering with site networks—sometimes through direct ownership, sometimes through curated alliances.

3. 4 Clear Trends In Outsourced Clinical Services 8/4/2025

   Discover the four dominant trends in outsourced clinical and eClinical services for 2025, with insights derived from an annual survey by L.E.K. Consulting.

4. How An Australia-First Strategy Cut 63% From Our R&D Spend 7/10/2025

   Etira CEO Russell Hayward explains how conducting the company's early-stage trials in Australia has yielded big savings, shortened timelines, and produced FDA-ready data.

5. It's Time To Change How We Engage Research Sites 6/25/2025

   Site operations expert Maria Ladd argues for a major change in how sponsors and CROs communicate and work with clinical research sites.

6. Why CRA Proficiency Needs A Boost From Better Assessment And Training 6/20/2025

   CRAs intend to fulfill clinical research’s commitment to patient safety. Yet, some fall short of true proficiency, and Gerald DeWolfe contends better evaluations and training can help.

7. 5 Ways To Make Your Investigator Meetings Fun And Functional 6/17/2025

   Discover five ways CROs and sponsors can better engage and communicate with site staff for better relationships and better trials.

8. Hidden Compliance Risks In Start-Up That Could Derail Your Clinical Trial 6/13/2025

   Kulkarni Law Firm Senior Attorney Edye T. Edens explores the risks embedded in clinical trial start-up activities, such as site activation, contract execution, delegation of responsibilities, and cross-border data flows.

9. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

   RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

10. When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover 6/6/2025

    Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.